BENITEC BIOPHARMA INC. (BNTC) Operating income 2019–2026
BENITEC BIOPHARMA INC. (BNTC) annual operating income history from SEC filings — each fiscal year as reported.
-$51.2MFY2026 · since FY2019: $2.6M → -$51.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$51.2M | -22.6% |
| FY2025 | -$41.8M | -85.7% |
| FY2024 | -$22.5M | -17.9% |
| FY2023 | -$19.1M | -6.9% |
| FY2022 | -$17.9M | -31.3% |
| FY2021 | -$13.6M | -64.2% |
| FY2020 | -$8.3M | -420.6% |
| FY2019 | $2.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More BNTC financial trends
BNTC RevenueBNTC Net incomeBNTC Net marginBNTC Gross profitBNTC Gross marginBNTC Operating marginBNTC Operating cash flowBNTC Free cash flowBNTC Capital expendituresBNTC Return on equityBNTC Stock buybacksBNTC Dividends paidBNTC Total assetsBNTC Total liabilitiesBNTC Shareholders’ equityBNTC overview →